Collegium Pharmaceutical, Inc.

NASDAQ:COLL

37.19 (USD) • At close September 6, 2024
Bedrijfsnaam Collegium Pharmaceutical, Inc.
Symbool COLL
Munteenheid USD
Prijs 37.19
Beurswaarde 1,198,031,222
Dividendpercentage 0%
52-weken bereik 20.95 - 40.95
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Joseph J. Ciaffoni
Website https://www.collegiumpharma.com

An error occurred while fetching data.

Over Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to

Vergelijkbare Aandelen

BioLife Solutions, Inc. logo

BioLife Solutions, Inc.

BLFS

23.79 USD

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

38.83 USD

Bioventus Inc. logo

Bioventus Inc.

BVS

9.53 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

5.27 USD

Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX

16.24 USD

Quantum-Si incorporated logo

Quantum-Si incorporated

QSI

0.911 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)